Norges Bank
CCXI

Norges Bank’s ChemoCentryx, Inc. CCXI Stock Holding History

Norges Bank’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,864,893
Closed -$96.3M – 2207
2022
Q3 		$96.3M Buy
1,864,893
+1,315,789
+240% +$54.4M 0.03% 519
2022
Q2 		$13.6M Sell
549,104
-590,836
-52% -$13M ﹤0.01% 1424
2022
Q1 		$28.6M Buy
1,139,940
+40,116
+4% +$1.13M 0.01% 1197
2021
Q4 		$40M Buy
1,099,824
+744,910
+210% +$26.1M 0.01% 1066
2021
Q3 		$6.07M Sell
354,914
-83,910
-19% -$1.31M ﹤0.01% 1897
2021
Q2 		$5.88M Buy
438,824
+267,769
+157% +$6.6M ﹤0.01% 1881
2021
Q1 		$8.77M Sell
171,055
-293,042
-63% -$17.6M ﹤0.01% 1819
2020
Q4 		$28.7M Sell
464,097
-64,567
-12% -$3.7M 0.01% 1345
2020
Q3 		$29M Sell
528,664
-14,038
-3% -$756K 0.01% 1182
2020
Q2 		$31.2M Buy
542,702
+91,541
+20% +$4.98M 0.01% 1160
2020
Q1 		$18.1M Buy
+451,161
New +$19.2M 0.01% 1314

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Norges Bank's CCXI Position: Q4 2022 in Review

Norges Bank sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 1,864,893 shares — an estimated $96.3M sold.

Norges Bank first reported a position in CCXI in Q1 2020 and held it in 11 quarters. The position peaked at $96.3M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Norges Bank reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Norges Bank sold 1,864,893 ChemoCentryx, Inc. shares in Q4 2022, an estimated $96.3M.
  • Norges Bank first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 11 quarters.
  • Norges Bank's ChemoCentryx, Inc. position peaked at $96.3M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Norges Bank's 13F filing for Q4 2022, filed 14 Feb 2023.